Ads
related to: latest news schizophrenia treatment optionseverydayhealth.com has been visited by 10K+ users in the past month
consumerhippo.com has been visited by 100K+ users in the past month
consumerhorse.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Jake Goodman, MD, MBA is a psychiatry resident physician and a member of the ABC News Medical Unit. FDA approves 1st new drug for schizophrenia in more than 30 years originally appeared on abcnews ...
The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...
The medicine works in an entirely different way from existing treatments.
A new first-in-class antipsychotic that targets multiple neurotransmitter systems called lumateperone (ITI-007), was trialed and approved by the FDA in December 2019 for the treatment of schizophrenia in adults. [24] [26] [27] Lumateperone is a small molecule agent that shows improved safety, and tolerance.
Antipsychotic drug treatment is a key component of schizophrenia treatment recommendations by the National Institute of Health and Care Excellence (NICE), [23] the American Psychiatric Association, [24] and the British Society for Psychopharmacology. [25]
The Brief Negative Symptom Scale (BNSS) has been used to assess the effect of Ulotaront on the negative symptoms of schizophrenia. [18] In July 2023, the pharmaceutical company behind the drug announced that the drug had failed to outperform placebo in the treatment of acutely psychotic patients with schizophrenia, as measured by the PANSS. [19]
Ads
related to: latest news schizophrenia treatment optionseverydayhealth.com has been visited by 10K+ users in the past month
consumerhippo.com has been visited by 100K+ users in the past month
consumerhorse.com has been visited by 100K+ users in the past month